Morton Leslie A, Saludes Jonel P, Yin Hang
Department of Chemistry & Biochemistry, University of Colorado-Boulder, CO, USA.
J Vis Exp. 2012 Jun 22(64):4151. doi: 10.3791/4151.
Liposomes are artificially prepared vesicles consisting of natural and synthetic phospholipids that are widely used as a cell membrane mimicking platform to study protein-protein and protein-lipid interactions, monitor drug delivery, and encapsulation. Phospholipids naturally create curved lipid bilayers, distinguishing itself from a micelle. Liposomes are traditionally classified by size and number of bilayers, i.e. large unilamellar vesicles (LUVs), small unilamellar vesicles (SUVs) and multilamellar vesicles (MLVs). In particular, the preparation of homogeneous liposomes of various sizes is important for studying membrane curvature that plays a vital role in cell signaling, endo- and exocytosis, membrane fusion, and protein trafficking. Several groups analyze how proteins are used to modulate processes that involve membrane curvature and thus prepare liposomes of diameters <100 - 400 nm to study their behavior on cell functions. Others focus on liposome-drug encapsulation, studying liposomes as vehicles to carry and deliver a drug of interest. Drug encapsulation can be achieved as reported during liposome formation. Our extrusion step should not affect the encapsulated drug for two reasons, i.e. (1) drug encapsulation should be achieved prior to this step and liposomes should retain their natural biophysical stability, securely carrying the drug in the aqueous core. These research goals further suggest the need for an optimized method to design stable sub-micron lipid vesicles. Nonetheless, the current liposome preparation technologies (sonication, freeze-and-thaw, sedimentation) do not allow preparation of liposomes with highly curved surface (i.e. diameter <100 nm) with high consistency and efficiency, which limits the biophysical studies of an emerging field of membrane curvature sensing. Herein, we present a robust preparation method for a variety of biologically relevant liposomes. Manual extrusion using gas-tight syringes and polycarbonate membranes, is a common practice but heterogeneity is often observed when using pore sizes <100 nm due to due to variability of manual pressure applied. We employed a constant pressure-controlled extrusion apparatus to prepare synthetic liposomes whose diameters range between 30 and 400 nm. Dynamic light scattering (DLS), electron microscopy and nanoparticle tracking analysis (NTA) were used to quantify the liposome sizes as described in our protocol, with commercial polystyrene (PS) beads used as a calibration standard. A near linear correlation was observed between the employed pore sizes and the experimentally determined liposomes, indicating high fidelity of our pressure-controlled liposome preparation method. Further, we have shown that this lipid vesicle preparation method is generally applicable, independent of various liposome sizes. Lastly, we have also demonstrated in a time course study that these prepared liposomes were stable for up to 16 hours. A representative nano-sized liposome preparation protocol is demonstrated below.
脂质体是由天然和合成磷脂制成的人工制备囊泡,被广泛用作模拟细胞膜的平台,以研究蛋白质-蛋白质和蛋白质-脂质相互作用、监测药物递送和包封。磷脂天然形成弯曲的脂质双层,这使其有别于胶束。脂质体传统上按双层的大小和数量分类,即大单层囊泡(LUVs)、小单层囊泡(SUVs)和多层囊泡(MLVs)。特别地,制备各种大小均一的脂质体对于研究膜曲率很重要,膜曲率在细胞信号传导、胞吞和胞吐作用、膜融合以及蛋白质运输中起着至关重要的作用。几个研究小组分析了蛋白质如何用于调节涉及膜曲率的过程,因此制备直径<100 - 400 nm的脂质体以研究它们对细胞功能的影响。其他小组则专注于脂质体-药物包封,将脂质体作为携带和递送感兴趣药物的载体进行研究。如在脂质体形成过程中所报道的那样,可以实现药物包封。我们的挤压步骤不应影响包封的药物,原因有两个,即(1)药物包封应在此步骤之前完成,并且脂质体应保持其天然的生物物理稳定性,将药物安全地携带在水相中。这些研究目标进一步表明需要一种优化的方法来设计稳定的亚微米脂质囊泡。尽管如此,目前的脂质体制备技术(超声处理、冻融、沉淀)无法以高一致性和效率制备具有高度弯曲表面(即直径<100 nm)的脂质体,这限制了膜曲率传感这一新兴领域的生物物理研究。在此,我们提出了一种用于制备多种生物学相关脂质体的稳健方法。使用气密注射器和聚碳酸酯膜进行手动挤压是一种常见做法,但由于施加的手动压力的可变性,当使用孔径<100 nm时,通常会观察到异质性。我们采用恒压控制挤压装置来制备直径在30至400 nm之间的合成脂质体。如我们方案中所述,使用动态光散射(DLS)、电子显微镜和纳米颗粒跟踪分析(NTA)来量化脂质体大小,使用商业聚苯乙烯(PS)珠作为校准标准。在所使用的孔径与实验确定的脂质体之间观察到近乎线性的相关性,表明我们的压力控制脂质体制备方法具有高保真度。此外,我们已经表明这种脂质囊泡制备方法普遍适用,与各种脂质体大小无关。最后,我们还在一项时间进程研究中证明,这些制备的脂质体在长达16小时内是稳定的。下面展示了一个代表性的纳米级脂质体制备方案。